Cell lineage as a predictor of immune response in neuroblastoma
Satyaki Sengupta(Harvard University), Rani E. George(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Cited by 8
Related Papers
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells
|Nature|2019|142
The MYCN 5′ UTR as a therapeutic target in neuroblastoma
|Cell Reports|2024|5